By Brent MacDonald
The company behind the NBA’s NFT trading cards raises over $300 million in its latest round By Brent MacDonald – Principal @ Rising Tide VC Dapper Labs, the blockchain company behind the NBA’s collectibles marketplace ‘Top Shot’, closed a major round of funding toward its goal: NFTs (Non-Fungible Tokens) for all. The company announced this […]
By Brent Macdonald
Rising Tide Newsletter Welcome to the Rising Tide 1st Quarter 2021 Newsletter that highlights updates from our 70+ companies whose stories will inspire you. We hope you’ll enjoy and as always, send us your suggestions info@rtf.vc We look forward to your feedback and everlasting cooperation. CEO SPOTLIGHT Andrew Butt, the Co-founder & CEO of Enable, a […]
By Brent MacDonald
By Brent MacDonald – Principal @ Rising Tide VC As biology pervades many aspects of life, advanced automation tools are in demand. Volta Labs is an MIT Media Lab spin-off company that makes programmable fluidic chips for biological automation. To build this next generation automation tool, the Volta Labs team combines principles of computing with material […]
By Brent MacDonald
By Brent MacDonald – Principal @ Rising Tide VC Unnatural Products mission is solving the problem of ‘undruggable’ proteins—the roughly 80% to 90% of proteins in the body that have eluded drug makers. Some proteins are inaccessible because they lack a binding “pocket” where drugs can dock. What is more, traditional drug development approaches are […]
By Brent MacDonald
By Brent MacDonald – Principal at Rising Tide VC Precision Nanosystems Inc’s (PNI) mission is to accelerate the creation of transformative medicine that significantly impacts human well being. The Company creates end-to-end solutions that empower researchers to harness powerful nanotechnology to transform our understanding and treatment of rare diseases, cancer, and infectious diseases. Leading academic institutions, […]
By Brent MacDonald
By Brent MacDonald – Principal @ Rising Tide VC Despite cheap, abundant genetics tools and information, many aspects of healthcare research remain constrained and complex. For example, while the cost of DNA sequencing has declined dramatically, innovations in personalized medicine, drug research, and early-stage pharmaceutical discovery and development have not kept up due to constraints […]